A phase 3 clinical trial found that adding immunotherapy, aglatimagene, to valacyclovir and radiation therapy improved ...

The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...

Low testosterone may increase the risk of aggressive prostate cancer progression during active surveillance. Learn more about the findings.

Olympus Corporation (Olympus), a global MedTech company committed to advancing endoscopy-enabled care, announced today it has signed a definitive agreement to acquire BioProtect Ltd. (BioProtect), a ...

CYP2D6 poor metabolizers had ~5-fold higher payload exposure and excess grade ≥3 mucositis, neutropenia, febrile neutropenia, ...

The cognitive effects men with advanced prostate cancer experience during treatment may vary based on the therapy they ...

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than current tests, according to a U.K.-wide study led by UCL researchers. The ...

Pocono Raceway, in partnership with Man Cave Health, will once again bring its impactful men’s health initiative to fans ...

President Donald Trump hasn’t said where things stand with Iran after announcing this morning that he was meeting in the White House Situation Room to make a final decision on a proposed deal.

New Clinical Data Reinforce Proclarix® Performance in Reducing Overdiagnosis and Unnecessary Biopsies; Multi-Center PRIME Study Initiated in Collaboration with Labcorp; European Commercial Expansion ...

Q1 Galleri® Revenue Grew 37% Year-Over-Year to $39.8 Million, and Test Volume Increased 50% to More Than 56,000 Announced Plans to Integrate the Galleri Test Into Epic ...